Conjugated equine estrogen-improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 1, 2001, Pages 48-52

  Friday, Karen E ^a,b   Dong, Caiping ^a   Fontenot, Rhonda U ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; CONJUGATED ESTROGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ESTROGEN THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ANIMALS; APOLIPOPROTEINS B; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ESTROGENS, CONJUGATED (USP); FEMALE; HORSES; HUMANS; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 0035142209     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.1.48     Document Type: Article

References (27)

1. Cardiovascular disease in women
2. A prospective study of maturity-onset diabetes and risk of coronary heart disease and stroke in women
3. Atherogenesis in diabetes
4. Diabetes mellitus and cardiovascular disease in women
5. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?
6. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
8. Acute vascular effects of estrogen in postmenopausal women
9. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study
10. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
11. Estrogen replacement therapy for postmenopausal women with diabetes
12. Quantification of cholesterol in all lipoprotein classes by VAP-II method
13. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non-insulin-dependent diabetes mellitus
14. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
15. Effect of 17β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus
16. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism and vascular factors in type 2 diabetes: A prospective study
17. Sex steroid influence on hepatic gluconeogenesis and glycogen formation
18. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment
19. Type A behavior pattern, heart disease risk factors, and estrogen replacement in postmenopausal women: The Rancho Bernardo Study
20. Effects of low doses of transdermal 17-beta estradiol on carbohydrate metaboiism in postmenopausal women
21. Effect of postmenopausal hormone therapy on glucose and insulin concentrations
22. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure
23. Postmenopausal estrogens and risk of myocardial infarction in diabetic women
24. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
25. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
26. 17β-estradiol improves postprandial iipid metabolism in postmenopausal women
27. Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats